Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35123694

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2022 Feb 5
First author
Gershenson DM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2022 Feb 5;399(10324):499-501. doi: 10.1016/S0140-6736(21)02338-2.
    note
    Source null
    related pmid
    35123677
    relationship
    Comment in

Authors and identifiers

  1. name
    Gershenson DM
    type
    Author
  2. name
    Miller A
    type
    Author
  3. name
    Brady WE
    type
    Author
  4. name
    Paul J
    type
    Author
  5. name
    Carty K
    type
    Author
  6. name
    Rodgers W
    type
    Author
  7. name
    Millan D
    type
    Author
  8. name
    Coleman RL
    type
    Author
  9. name
    Moore KN
    type
    Author
  10. name
    Banerjee S
    type
    Author
  11. name
    Connolly K
    type
    Author
  12. name
    Secord AA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gershenson DM
    type
    Author
  2. name
    Miller A
    type
    Author
  3. name
    Brady WE
    type
    Author
  4. name
    Paul J
    type
    Author
  5. name
    Carty K
    type
    Author
  6. name
    Rodgers W
    type
    Author
  7. name
    Millan D
    type
    Author
  8. name
    Coleman RL
    type
    Author
  9. name
    Moore KN
    type
    Author
  10. name
    Banerjee S
    type
    Author
  11. name
    Connolly K
    type
    Author
  12. name
    Secord AA
    type
    Author
bibliography ids
  1. nci-bib-51e3c1f5a4c26fbf4e7e0253
book metadata
content sha256
e6e94c8a51a79d63865dc882a6d96268052d87eee6c445f5671713a786417cbb
document type
citation
dois
  1. 10.1016/S0140-6736(21)02175-9
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35123694
immutable id
pubmed:35123694@e6e94c8a51a79d63865dc882a6d96268052d87eee6c445f5671713a786417cbb
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10324
name
Lancet (London, England)
nlm unique id
2985213R
pages
541-553
volume
399
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2022 Feb 5;399(10324):499-501. doi: 10.1016/S0140-6736(21)02338-2.
    note
    Source null
    related pmid
    35123677
    relationship
    Comment in
outcomes validated
false
pmid
35123694
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
500810b3d910103f54266317524168cc11182c4b83d1bce96e227e4cd641670e
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Feb 5
precision
day
year
2022
publication types
  1. Clinical Trial, Phase II
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35123694/
title
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.

Preserved source evidence · Not medical advice